LOI, GIULIA
LOI, GIULIA
100008 - Dipartimento di medicina sperimentale
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.002 secondi).
Heme oxygenase 1 in BRAFV600 melanoma: Evidence for a role in chemoresistance, immuno-escape and angiogenesis.
2021-04-22 Loi, Giulia
HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition
2019-01-01 Furfaro, A.; Ottonello, S.; Loi, Giulia; Cossu, I.; Piras, S.; Spagnolo, F.; Queirolo, P.; Marinari, U. M.; Moretta, L.; Pronzato, M. A.; Mingari, M. C.; Pietra, G.; Nitti, M.
HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia
2022-01-01 Furfaro, Anna Lisa; Loi, Giulia; Ivaldo, Caterina; Passalacqua, Mario; Pietra, Gabriella; Mann, Giovanni Enrico; Nitti, Mariapaola
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Heme oxygenase 1 in BRAFV600 melanoma: Evidence for a role in chemoresistance, immuno-escape and angiogenesis. | 22-apr-2021 | Loi, Giulia | |
| HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition | 1-gen-2019 | Furfaro, A.; Ottonello, S.; Loi, Giulia; Cossu, I.; Piras, S.; Spagnolo, F.; Queirolo, P.; Marinari, U. M.; Moretta, L.; Pronzato, M. A.; Mingari, M. C.; Pietra, G.; Nitti, M. | |
| HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia | 1-gen-2022 | Furfaro, Anna Lisa; Loi, Giulia; Ivaldo, Caterina; Passalacqua, Mario; Pietra, Gabriella; Mann, Giovanni Enrico; Nitti, Mariapaola |